CLEARWATER ANALYTICS HDS-A (CWAN) Fundamental Analysis & Valuation

NYSE:CWANUS1851231068

Current stock price

23.49 USD
+0.01 (+0.04%)
At close:
23.49 USD
0 (0%)
After Hours:

This CWAN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. CWAN Profitability Analysis

1.1 Basic Checks

  • CWAN had positive earnings in the past year.
  • In the past year CWAN had a positive cash flow from operations.
  • In the past 5 years CWAN reported 4 times negative net income.
  • CWAN had a positive operating cash flow in each of the past 5 years.
CWAN Yearly Net Income VS EBIT VS OCF VS FCFCWAN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M

1.2 Ratios

  • CWAN's Return On Assets of -1.29% is in line compared to the rest of the industry. CWAN outperforms 53.96% of its industry peers.
  • With a Return On Equity value of -1.93%, CWAN perfoms like the industry average, outperforming 58.63% of the companies in the same industry.
Industry RankSector Rank
ROA -1.29%
ROE -1.93%
ROIC N/A
ROA(3y)10.38%
ROA(5y)5.42%
ROE(3y)11.36%
ROE(5y)5.39%
ROIC(3y)N/A
ROIC(5y)N/A
CWAN Yearly ROA, ROE, ROICCWAN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60

1.3 Margins

  • CWAN's Gross Margin of 67.29% is in line compared to the rest of the industry. CWAN outperforms 48.20% of its industry peers.
  • CWAN's Gross Margin has declined in the last couple of years.
  • The Profit Margin and Operating Margin are not available for CWAN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 67.29%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.8%
GM growth 5Y-1.83%
CWAN Yearly Profit, Operating, Gross MarginsCWAN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60 80

4

2. CWAN Health Analysis

2.1 Basic Checks

  • CWAN does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for CWAN has been increased compared to 1 year ago.
  • Compared to 5 years ago, CWAN has more shares outstanding
  • Compared to 1 year ago, CWAN has a worse debt to assets ratio.
CWAN Yearly Shares OutstandingCWAN Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M
CWAN Yearly Total Debt VS Total AssetsCWAN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

2.2 Solvency

  • An Altman-Z score of 4.53 indicates that CWAN is not in any danger for bankruptcy at the moment.
  • CWAN's Altman-Z score of 4.53 is fine compared to the rest of the industry. CWAN outperforms 75.18% of its industry peers.
  • CWAN has a debt to FCF ratio of 5.34. This is a neutral value as CWAN would need 5.34 years to pay back of all of its debts.
  • CWAN has a Debt to FCF ratio (5.34) which is in line with its industry peers.
  • A Debt/Equity ratio of 0.40 indicates that CWAN is not too dependend on debt financing.
  • With a Debt to Equity ratio value of 0.40, CWAN is not doing good in the industry: 62.59% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF 5.34
Altman-Z 4.53
ROIC/WACCN/A
WACC11.09%
CWAN Yearly LT Debt VS Equity VS FCFCWAN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B 2B

2.3 Liquidity

  • A Current Ratio of 1.83 indicates that CWAN should not have too much problems paying its short term obligations.
  • The Current ratio of CWAN (1.83) is comparable to the rest of the industry.
  • A Quick Ratio of 1.83 indicates that CWAN should not have too much problems paying its short term obligations.
  • With a Quick ratio value of 1.83, CWAN perfoms like the industry average, outperforming 55.04% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.83
Quick Ratio 1.83
CWAN Yearly Current Assets VS Current LiabilitesCWAN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

9

3. CWAN Growth Analysis

3.1 Past

  • CWAN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 20.00%, which is quite impressive.
  • Measured over the past years, CWAN shows a very strong growth in Earnings Per Share. The EPS has been growing by 32.91% on average per year.
  • CWAN shows a strong growth in Revenue. In the last year, the Revenue has grown by 61.88%.
  • The Revenue has been growing by 29.19% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)20%
EPS 3Y32.91%
EPS 5YN/A
EPS Q2Q%15.38%
Revenue 1Y (TTM)61.88%
Revenue growth 3Y34.08%
Revenue growth 5Y29.19%
Sales Q2Q%71.95%

3.2 Future

  • The Earnings Per Share is expected to grow by 26.28% on average over the next years. This is a very strong growth
  • CWAN is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 17.47% yearly.
EPS Next Y32.85%
EPS Next 2Y29.25%
EPS Next 3Y27.7%
EPS Next 5Y26.28%
Revenue Next Year29.23%
Revenue Next 2Y23.63%
Revenue Next 3Y21.12%
Revenue Next 5Y17.47%

3.3 Evolution

  • Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
CWAN Yearly Revenue VS EstimatesCWAN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 500M 1B 1.5B 2B 2.5B
CWAN Yearly EPS VS EstimatesCWAN Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 1 2 3

2

4. CWAN Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 43.50, the valuation of CWAN can be described as expensive.
  • CWAN's Price/Earnings is on the same level as the industry average.
  • The average S&P500 Price/Earnings ratio is at 24.89. CWAN is valued rather expensively when compared to this.
  • CWAN is valuated quite expensively with a Price/Forward Earnings ratio of 32.74.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of CWAN is on the same level as its industry peers.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 22.19, CWAN is valued a bit more expensive.
Industry RankSector Rank
PE 43.5
Fwd PE 32.74
CWAN Price Earnings VS Forward Price EarningsCWAN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CWAN is on the same level as its industry peers.
  • CWAN's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 45.04
EV/EBITDA 98.54
CWAN Per share dataCWAN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • A more expensive valuation may be justified as CWAN's earnings are expected to grow with 27.70% in the coming years.
PEG (NY)1.32
PEG (5Y)N/A
EPS Next 2Y29.25%
EPS Next 3Y27.7%

0

5. CWAN Dividend Analysis

5.1 Amount

  • CWAN does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

CWAN Fundamentals: All Metrics, Ratios and Statistics

CLEARWATER ANALYTICS HDS-A

NYSE:CWAN (3/27/2026, 8:09:59 PM)

After market: 23.49 0 (0%)

23.49

+0.01 (+0.04%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)02-18
Earnings (Next)04-29
Inst Owners105.99%
Inst Owner Change10.22%
Ins Owners1.15%
Ins Owner Change31.8%
Market Cap6.94B
Revenue(TTM)731.37M
Net Income(TTM)-39.12M
Analysts72.5
Price Target25.03 (6.56%)
Short Float %6.62%
Short Ratio1.6
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-3.79%
Min EPS beat(2)-6.22%
Max EPS beat(2)-1.36%
EPS beat(4)1
Avg EPS beat(4)-1.75%
Min EPS beat(4)-6.22%
Max EPS beat(4)2.56%
EPS beat(8)4
Avg EPS beat(8)2.8%
EPS beat(12)8
Avg EPS beat(12)7.86%
EPS beat(16)11
Avg EPS beat(16)6.89%
Revenue beat(2)0
Avg Revenue beat(2)-1.43%
Min Revenue beat(2)-1.6%
Max Revenue beat(2)-1.26%
Revenue beat(4)1
Avg Revenue beat(4)-0.25%
Min Revenue beat(4)-1.6%
Max Revenue beat(4)2.43%
Revenue beat(8)4
Avg Revenue beat(8)0.2%
Revenue beat(12)6
Avg Revenue beat(12)0.08%
Revenue beat(16)8
Avg Revenue beat(16)-0.03%
PT rev (1m)-0.74%
PT rev (3m)-14.44%
EPS NQ rev (1m)0.89%
EPS NQ rev (3m)3.48%
EPS NY rev (1m)1.2%
EPS NY rev (3m)2.05%
Revenue NQ rev (1m)-1.87%
Revenue NQ rev (3m)-1.87%
Revenue NY rev (1m)-0.14%
Revenue NY rev (3m)-0.13%
Valuation
Industry RankSector Rank
PE 43.5
Fwd PE 32.74
P/S 9.49
P/FCF 45.04
P/OCF 39.46
P/B 3.43
P/tB 108.28
EV/EBITDA 98.54
EPS(TTM)0.54
EY2.3%
EPS(NY)0.72
Fwd EY3.05%
FCF(TTM)0.52
FCFY2.22%
OCF(TTM)0.6
OCFY2.53%
SpS2.48
BVpS6.84
TBVpS0.22
PEG (NY)1.32
PEG (5Y)N/A
Graham Number9.12
Profitability
Industry RankSector Rank
ROA -1.29%
ROE -1.93%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 67.29%
FCFM 21.07%
ROA(3y)10.38%
ROA(5y)5.42%
ROE(3y)11.36%
ROE(5y)5.39%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.8%
GM growth 5Y-1.83%
F-Score3
Asset Turnover0.24
Health
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF 5.34
Debt/EBITDA 10.46
Cap/Depr 25.48%
Cap/Sales 2.98%
Interest Coverage N/A
Cash Conversion 225.93%
Profit Quality N/A
Current Ratio 1.83
Quick Ratio 1.83
Altman-Z 4.53
F-Score3
WACC11.09%
ROIC/WACCN/A
Cap/Depr(3y)41.76%
Cap/Depr(5y)84.08%
Cap/Sales(3y)1.89%
Cap/Sales(5y)2.05%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)20%
EPS 3Y32.91%
EPS 5YN/A
EPS Q2Q%15.38%
EPS Next Y32.85%
EPS Next 2Y29.25%
EPS Next 3Y27.7%
EPS Next 5Y26.28%
Revenue 1Y (TTM)61.88%
Revenue growth 3Y34.08%
Revenue growth 5Y29.19%
Sales Q2Q%71.95%
Revenue Next Year29.23%
Revenue Next 2Y23.63%
Revenue Next 3Y21.12%
Revenue Next 5Y17.47%
EBIT growth 1Y-162.83%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year35.42%
EBIT Next 3Y27.09%
EBIT Next 5Y23.19%
FCF growth 1Y123.14%
FCF growth 3Y45.29%
FCF growth 5YN/A
OCF growth 1Y136.67%
OCF growth 3Y44.74%
OCF growth 5YN/A

CLEARWATER ANALYTICS HDS-A / CWAN Fundamental Analysis FAQ

What is the ChartMill fundamental rating of CLEARWATER ANALYTICS HDS-A (CWAN) stock?

ChartMill assigns a fundamental rating of 4 / 10 to CWAN.


What is the valuation status for CWAN stock?

ChartMill assigns a valuation rating of 2 / 10 to CLEARWATER ANALYTICS HDS-A (CWAN). This can be considered as Overvalued.


What is the profitability of CWAN stock?

CLEARWATER ANALYTICS HDS-A (CWAN) has a profitability rating of 2 / 10.


Can you provide the financial health for CWAN stock?

The financial health rating of CLEARWATER ANALYTICS HDS-A (CWAN) is 4 / 10.